What's new in Interventional Cardiology

Designed By & For you, PCRonline offers a wealth of constantly updated information on interventional cardiovascular medicine. Whether you’re looking for the latest articles, cases, course presentations or videos, check out these pages regularly, or better yet, sign up for our newsletter and remain in the know!

Filter By

86 results

2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James on behalf of Swedish cardiovascular registry experts

20 May 2025

The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.

2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James on behalf of Swedish cardiovascular registry experts

The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma

01 Apr 2025

Mirvat Alasnag provides her take on the Lancet Commission for atherosclerosis published during the ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma

International Women's Day 2025: Raising awareness of aortic stenosis in women: - a silent killer

08 Mar 2025

It was a day in October last year when I had a meeting with patients’ group in UK. At the time, I needed to discuss with them why a registry on valvular heart disease and sex disparities is needed. The camaraderie was incredible and the discussion...

Julia Grapsa

Author

Julia Grapsa
Aortic stenosis in women: a silent killer

Aortic Stenosis in Women: causes, symptoms and treatment options

06 Mar 2025

The patient booklets on this page aim to help women get a better understanding of the condition, recognize symptoms, and explore options to get the right care at the right time.

Aortic Stenosis in Women

Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial

01 Apr 2025

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Elad Asher

Author

Elad Asher
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

29 Mar 2025

Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.

Luigi Biasco

Author

Luigi Biasco
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

31 Mar 2025

Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3

02 Apr 2025

Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
FFR-guided PCI vs CABG: 5-year results of the FAME 3 trial

Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial

02 Apr 2025

Alex Sticchi interviews Saibal Kar about the two-year results of the Triluminate pivotal trial, unveiled at ACC.25 in Chicago.

After revisiting the one-year findings and outlining the study design, Saibal Kar highlights key takeaways: at two years, TriClip therapy significantly reduced heart failure hospitalisations compared to medical...

Author

Saibal Kar
Alessandro Sticchi

Author

Alessandro Sticchi
Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial